Notes: 1) As noted in a diff thread, increase in cash for the quarter is almost all due to exchange rate gains (+$1.542m) 2) Excluding currency gains, it was a cash-flow positive quarter, but only just: $198k (cash from operations $944k minus investing ($746k) (which includes equipment, and capitalisation of research). YTD cash-negative approx $3.5m 3) No new customers"Chart 1: Total Contract Value (TCV) of quarterly sales orders since Q1 FY21 ... highlights the variable nature of sales orders over time. In Q2 FY25, add-ons and expansions accounted for 67% of sales orders with renewals making up the remainder." 4) Increased cash outflow by $2.2m in staff and admin/corporate costs compared to 1H2024: $16.97m, up from $14.72m same last year 5) To counter that, some of the capitalised research costs are part of a project that "...is expected to deliver annualised cost savings of approximately A$1M when it is fully implemented" I look forward to hearing more about that! 6) SHARE buy-back: in principle, I agree these do add value: assume 35-40c per share buy back = 12.5-14.3m shares (out of approx 241m on issue).
M7T Price at posting:
41.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)